<DOC>
	<DOCNO>NCT02027389</DOCNO>
	<brief_summary>The objective study evaluate impact Alere &amp; # 8482 ; PBP2a test combine pharmacist review antimicrobial therapy , clinical outcome cost hospitalized patient sterile site S. aureus infection .</brief_summary>
	<brief_title>Impact Rapid Detection MRSA</brief_title>
	<detailed_description />
	<mesh_term>Staphylococcal Infections</mesh_term>
	<criteria>Inclusion criterion : 1 . Inpatients ( adult child ) Mayo Clinic , Rochester sterile source S. aureus culture ( control intervention period ) 2 . Above , rapid PBP2a testing ( intervention period ) . Exclusion criterion : 1 . Patients polymicrobial culture ( i.e. , growth S. aureus plus organisms culture ) . 2 . Patients provide MN authorization use medical record research . 3 . Patients FilmArray Blood culture identification diagnostic test perform index S. aureus blood culture . 4 . Patients sterile source S. aureus culture within prior 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>MSSA , MRSA</keyword>
</DOC>